Shannon River Fund Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-34,423
Closed -$8.94M 25
2019
Q2
$8.94M Buy
34,423
+2,810
+9% +$563K 1.42% 18
2019
Q1
$5.23M Buy
31,613
+14,830
+88% +$2.41M 0.91% 24
2018
Q4
$1.82M Sell
16,783
-22,844
-58% -$3.85M 0.52% 28
2018
Q3
$9.92M Buy
+39,627
New +$8.53M 1.58% 17

Other funds holding CDLX

Shannon River Fund Management's CDLX Position: Q3 2019 in Review

Shannon River Fund Management sold out of Cardlytics (CDLX) in Q3 2019, closing a stake of 34,423 shares — an estimated $8.94M sold.

Shannon River Fund Management first reported a position in CDLX in Q3 2018 and held it in 4 quarters. The position peaked at $9.92M in Q3 2018. 117 funds tracked by Wall St. Rank hold CDLX as of Q3 2019.

  • Shannon River Fund Management reported no remaining Cardlytics position as of Q3 2019 after selling out during the quarter.
  • Shannon River Fund Management sold 34,423 Cardlytics shares in Q3 2019, an estimated $8.94M.
  • Shannon River Fund Management first reported a position in Cardlytics in Q3 2018 and held it in 4 quarters.
  • Shannon River Fund Management's Cardlytics position peaked at $9.92M in Q3 2018.
  • 117 funds tracked by Wall St. Rank held Cardlytics as of Q3 2019.

Based on Shannon River Fund Management's 13F filing for Q3 2019, filed 14 Nov 2019.